Drugs / Berlim 25/20 association
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04602754 | Dec 2023 → May 2026 overdue | type 2 diabetes mellitus | EMS | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Berlim 25/20 association | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04602754 ↗ |
| Route | Oral | “1 tablet Berlim 25/20 association, oral;” NCT04602754 ↗ |